SMMT - Summit Therapeutics Inc.
14.94
-0.440 -2.945%
Share volume: 2,431,342
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$15.38
-0.44
-0.03%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 02-24-2025 | 05-01-2025 | 10-20-2025 | 02-23-2026 | |
| Cash flow financing | -23.612 M | 7.677 M | 33.813 M | 573.821 M | |
| Other financing cash flows | 497.000 K | 5.658 M | 0.000 | 0.000 | |
| Cash flow | 11.197 M | 106.619 M | -59.338 M | -13.274 M | |
| Net income | -61.203 M | -62.913 M | -231.793 M | -219.172 M | |
| Depreciation | 22.000 K | 25.000 K | 42.000 K | 42.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 83.482 M | 160.110 M | -71.000 K | -485.157 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 14.000 K | 422.000 K | 71.000 K | 164.000 K | |
| Cash Change | 11.107 M | 106.657 M | -59.316 M | -13.293 M |